MEK1/MAPK signaling also regulates cell growth and/or differentiation, but is not typically thought of as a key antiestrogen resistance mechanism or as a key effector of cell survival in breast cancer cells undergoing hormonal therapy [26]. The gene discussed is MAP2K1; the disease is breast cancer.